Targeting the synapse in Alzheimer’s Disease
Recording · Dec 14, 2020
Johanna Jackson, UK Dementia Research Institute at Imperial College London
Molecular Biology seminar by Subhojit Roy, MD, PhD, Professor of Pathology and Neuroscience, University of Wisconsin-Madison
Hosted by Ad hoc
Monday 23:30–00:40 New York (GMT-5)
Ended
Alpha synuclein and Lrrk2 are key players in Parkinson's disease and related disorders, but their normal role has been confusing and controversial. Data from acute gene-editing based knockdown, followed by functional assays, will be presented.
We use cookies for analytics.